TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 25 filers reported holding TSCAN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $226,048 | +80.8% | 88,300 | +76.6% | 0.01% | +66.7% |
| Q2 2023 | $125,000 | -48.2% | 50,000 | -56.5% | 0.00% | -50.0% |
| Q1 2023 | $241,500 | +28.8% | 115,000 | 0.0% | 0.01% | +20.0% |
| Q4 2022 | $187,450 | -46.6% | 115,000 | 0.0% | 0.01% | -44.4% |
| Q3 2022 | $351,000 | -3.0% | 115,000 | 0.0% | 0.01% | +12.5% |
| Q2 2022 | $362,000 | +12.4% | 115,000 | 0.0% | 0.01% | +33.3% |
| Q1 2022 | $322,000 | +78.9% | 115,000 | +187.5% | 0.01% | +100.0% |
| Q4 2021 | $180,000 | – | 40,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 630,000 | $1,323,000 | 30.82% |
| Deer Management Co. LLC | 1,245,505 | $2,615,561 | 0.24% |
| Simplify Asset Management Inc. | 546,916 | $1,148,524 | 0.16% |
| Alphabet Inc. | 1,077,080 | $2,261,868 | 0.12% |
| Newtyn Management, LLC | 236,800 | $497,280 | 0.10% |
| DC Investments Management, LLC | 35,563 | $74,682 | 0.09% |
| Privium Fund Management (UK) Ltd | 15,825 | $40,987 | 0.03% |
| Baker Brothers Advisors | 2,784,792 | $5,848,063 | 0.03% |
| Tekla Capital Management LLC | 200,000 | $420,000 | 0.02% |
| NewEdge Wealth, LLC | 91,463 | $192,072 | 0.01% |